Clinical effects of transumbilical laparoendoscopic single-site extracorporeal surgery in treatment of giant ovarian cysts and huge cystic pelvic masses

Extracorporeal surgery in giant ovarian cysts and huge cystic

Abstract

Objective: To explore the clinical efficacy of transumbilical laparoendoscopic single-site extracorporeal surgery (TU-LESS-E) in the treatment of giant ovarian cysts and huge cystic pelvic masses.

Methodology: This was a retrospective study. Sixty patients diagnosed with giant ovarian cysts and huge cystic pelvic masses undergoing laparoscopic ovarian cystectomy in Maternity & Child Care Center of Qinhuangdao from May 2022 to October 2024 were selected, and randomly divided into observation group and control group (n=30 each group). The control group was given conventional multiport laparoscopy, while the observation group was treated with TU-LESS-E cystectomy. Perioperative outcomes such as surgical duration, intraoperative blood loss and incidence of cystic fluid overflow, pain intensity six hours and 24 hours, one months and three months after surgery were compared between the two groups.

Results: No significant differences were found in intraoperative blood loss or surgical duration between the two groups (p> 0.05). The incidence of cystic fluid overflow in the observation group was significantly lower than that in the control group (p< 0.05). The VAS score for incisional pain in the observation group was significantly lower than that in the control Group-6 and 24 hours after surgery (p< 0.05). The incidences of postoperative complications showed no significant differences between the two groups (p> 0.05).

Conclusion: TU-LESS-E presents good results in the treatment of giant ovarian cysts and huge cystic pelvic masses. It can reduce surgical traumas and pain, the occurrence of cystic fluid overflow, as well as impact on ovarian reserve.